| Trial ID: | L1625 |
| Source ID: | NCT02005718
|
| Associated Drug: |
Cholecalciferol
|
| Title: |
Impact of Vitamin D on Endothelial Function and Blood Biomarkers Including CD28 Null Cells in CKD
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
CKd Patients With Stage 3 and 4
|
| Interventions: |
DRUG: Cholecalciferol
|
| Outcome Measures: |
Primary: Flow mediated dilation, 16 weeks | Secondary: CD28 null cell frequency, 16 weeks|Blood biomarkers of endothelial function and inflammation, 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: St George's, University of London
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2010-06
|
| Completion Date: |
2013-06
|
| Results First Posted: |
|
| Last Update Posted: |
2013-12-09
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02005718
|
